Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | UKALL60+: identifying the standard of care for elderly patients with ALL

UKALL60+ is a trial for acute lymphoblastic leukemia (ALL) that aims to identify a standard of care for patients over the age of 60 yrs. David Marks, MD, PhD, from the University Hospitals Bristol NHS Foundation Trust, Bristol, UK, talks to us about the aims of the trial. Recorded at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.